Dr Ivan De Backer obtained his Ph.D. in Clinical Medicine from Imperial College London. His research identified the glucose-sensing function of an enzyme and discovered its role in the development of diabetes. He published his work in several scientific journals and presented his findings at a leading international conference. He also holds a BSc in Pharmacology from the University of Bath and completed a year-long internship at Janssen Pharmaceutica in his third year.
Ivan has a background in medical research and previously worked in the pharmaceutical industry. Prior to IDTechEx Ivan was a Senior Researcher at Eisai, where he optimised laboratory protocols and developed novel research methods in the field of neurodegenerative disease.
At IDTechEx, Ivan is a Technology Analyst with a focus on Life Sciences. His main activities include conducting target assessments, market forecasts and key player analysis for the delivery of research reports and consulting projects.